EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

Mohammadjavad Mehdizadeh Parizi, Reza Golchin Vafa, Amin Ahmadi, Reza Heydarzade, Mehrdad Sadeghi, Amin Khademolhossseini, Farhang Amiri, Soroush Khoshnood Mansorkhani, Ali Tavan, Nazanin Hosseini, Mohammad Montaseri, Seyed Ali Hosseini iD und 1 weitere

Journal of Interventional Cardiology · 2023

DOI: 10.1155/2023/5544440 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Interventional Cardiology, 2023. Verfasst von Mohammadjavad Mehdizadeh Parizi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Professor Kojuri Cardiology Clinic, Shiraz, Iran. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dual antiplatelet therapy with a P2Y12 inhibitor (e.g., clopidogrel and ticagrelor) and aspirin is recommended for at least one year after percutaneous coronary intervention (PCI) to prevent further myocardial infarction and stent thrombosis as the major adverse effects of PCI.

Methods

This randomized clinical trial was conducted from October 2022 to March 2023. Patients who had undergone elective PCI were included in the study. Patients were randomized into two different groups. One group took ASA 80 mg and clopidogrel 75 mg once daily, while the other took ASA 80 mg once daily and ticagrelor 90 mg twice daily. After six months of close follow-up, patients were asked to score their dyspnea on a 10-point Likert scale. They were also asked about dyspnea on exertion, paroxysmal nocturnal dyspnea (PND), bleeding, and the occurrence of major adverse cardiovascular events (MACEs).

Results

223 patients were allocated to the clopidogrel group and 214 to the ticagrelor group. In the ticagrelor group, 95 patients (44.3%) reported dyspnea at rest, compared with only 44 patients (19.7%) in the clopidogrel group ( P < 0.001). MACEs occurred in 7 patients (2.8%) in the ticagrelor group, compared with 16 (7.6%) in the clopidogrel group ( P = 0.031). Eight patients (3.8%) reported bleeding with ticagrelor, as did seven (3.2%) with clopidogrel ( P = 0.799).

Conclusions

New-onset dyspnea was recorded more frequently with ticagrelor than clopidogrel, yet fewer MACEs occurred with ticagrelor (ClinicalTrials.gov number: NCT05858918).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionAcute Coronary SyndromeHumansClopidogrelTicagrelorPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsHemorrhageAspirinDyspneaStentsTreatment Outcome

Substanzen

ClopidogrelTicagrelorPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsAspirin

Autor:innen und Institutionen

  • Professor Kojuri Cardiology Clinic, Shiraz, Iran.
  • Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Seyed Ali Hosseini, Javad Kojuri

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Mehdizadeh Parizi, M., Golchin Vafa, R., Ahmadi, A., Heydarzade, R., Sadeghi, M., Khademolhossseini, A., Amiri, F., Khoshnood Mansorkhani, S., Tavan, A., Hosseini, N., Montaseri, M., Hosseini, S. A., & Kojuri, J. (2023). Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial. Journal of Interventional Cardiology. https://doi.org/10.1155/2023/5544440

Vancouver

Mehdizadeh Parizi M, Golchin Vafa R, Ahmadi A, Heydarzade R, Sadeghi M, Khademolhossseini A, et al. Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial. Journal of Interventional Cardiology. 2023. doi:10.1155/2023/5544440

BibTeX
@article{MehdizadehParizi2023,
  author = {Mehdizadeh Parizi, Mohammadjavad and Golchin Vafa, Reza and Ahmadi, Amin and Heydarzade, Reza and Sadeghi, Mehrdad and Khademolhossseini, Amin and Amiri, Farhang and Khoshnood Mansorkhani, Soroush and Tavan, Ali and Hosseini, Nazanin and Montaseri, Mohammad and Hosseini, Seyed Ali and Kojuri, Javad},
  title = {Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial},
  journal = {Journal of Interventional Cardiology},
  year = {2023},
  doi = {10.1155/2023/5544440}
}
Kostenlos starten →